Form 4 STRYKER CORP For: Jun 26 Filed by: BRAINERD MARY K

Wed, 02 Sep 2026 16:08:00 -0400

si-local-file:///var/storage/secattach/20260902/27019023.html

Stryker completes first surgery using FDA-cleared Apple Vision Pro app

Tue, 01 Sep 2026 09:05:40 -0400

Stryker (NYSE: SYK) announced the completion of the first surgical procedure using its SportSuite Vision application on Apple Vision Pro, performed at Duke Health. The procedure was a hip arthroscopy, according to a company press release.

The FDA granted De Novo authorization for SportSuite Vision on July 17, making it what the agency designated as the first application authorized for intraoperative use with Apple Vision Pro. De Novo authorization is a regulatory pathway for novel, low-to-moderate risk medical devices.

SportSuite Vision displays arthroscopic video alongside HipCheck, HipMap, and CT imaging within the Apple Vision Pro headset, consolidating multiple data sources into a

Stryker introduces first of its kind FDA-authorized surgical application for Apple Vision Pro with hip arthroscopy case at nationally recognized academic medical center

Tue, 01 Sep 2026 09:05:00 -0400

SportSuite Vision brings spatial computing into the operating room, providing surgeons access to critical clinical information

Stryker announced the successful completion of the first surgical procedure, a hip arthroscopy, using SportSuite Vision on Apple Vision Pro at a leading academic medical center.
Stryker received FDA De Novo authorization for the first surgical application for intraoperative use with Apple Vision Pro, SportSuite Vision.
SportSuite Vision brings arthroscopic video, HipCheck, HipMap and CT imaging into a customizable spatial computing environment, helping surgeons access critical clinical information within one ergonomic field of view and streamline operating room workflows.

Stryker introduces first of its kind FDA-authorized surgical application for Apple Vision Pro with hip arthroscopy case at nationally recognized academic medical center

Tue, 01 Sep 2026 09:05:00 -0400

SportSuite Vision brings spatial computing into the operating room, providing surgeons access to critical clinical information

Stryker announced the successful completion of the first surgical procedure, a hip arthroscopy, using SportSuite Vision on Apple Vision Pro at a leading academic medical center.
Stryker received FDA De Novo authorization for the first surgical application for intraoperative use with Apple Vision Pro, SportSuite Vision.
SportSuite Vision brings arthroscopic video, HipCheck, HipMap and CT imaging into a customizable spatial computing environment, helping surgeons access critical clinical information within one ergonomic field of view and streamline operating room workflows.

Stryker agrees to acquire ZuriMED to expand shoulder portfolio

Mon, 31 Aug 2026 16:05:07 -0400

Stryker (NYSE: SYK) has signed a definitive agreement to acquire ZuriMED, a privately held medical device company that developed the FiberLocker System, a soft tissue augmentation technology for rotator cuff repair.

The FiberLocker System is designed to reduce a key clinical failure mode in rotator cuff repair by providing increased biomechanical strength during augmentation procedures. The technology is already commercialized.

The acquisition is intended to expand Stryker's shoulder portfolio across both sports medicine and arthroplasty segments. Rotator cuff augmentation is described as one of the faster-growing areas in sports medicine, according to data cited from Mordor Intelligence.

Andy Pierce, Group President of MedSurg

Stryker agrees to acquire ZuriMED to expand shoulder portfolio

Mon, 31 Aug 2026 16:05:07 -0400

Andy Pierce, Group President of MedSurg

Stryker signs definitive agreement to acquire ZuriMED to enhance its shoulder offering

Mon, 31 Aug 2026 16:05:00 -0400

Portage, Mich., USA, Aug. 31, 2026 (GLOBE NEWSWIRE) --

Stryker has signed a definitive agreement to acquire ZuriMED, developer of the FiberLocker System, a commercialized technology that provides a novel approach for rotator cuff augmentation designed for increased biomechanical strength.
The acquisition strengthens Stryker’s shoulder portfolio, enhancing its ability to support specialists across the continuum of care.
The FiberLocker System is a soft tissue augmentation technology designed to reduce the occurrence of a key clinical failure mode in rotator cuff repair, one of the fastest-growing segments in sports medicine.

Stryker (NYSE:SYK), a global leader in medical technologies, announced

Stryker signs definitive agreement to acquire ZuriMED to enhance its shoulder offering

Mon, 31 Aug 2026 16:05:00 -0400

Portage, Mich., USA, Aug. 31, 2026 (GLOBE NEWSWIRE) --

Stryker has signed a definitive agreement to acquire ZuriMED, developer of the FiberLocker System, a commercialized technology that provides a novel approach for rotator cuff augmentation designed for increased biomechanical strength.
The acquisition strengthens Stryker’s shoulder portfolio, enhancing its ability to support specialists across the continuum of care.
The FiberLocker System is a soft tissue augmentation technology designed to reduce the occurrence of a key clinical failure mode in rotator cuff repair, one of the fastest-growing segments in sports medicine.

Stryker (NYSE:SYK), a global leader in medical technologies, announced

Stryker to participate in the 2026 Wells Fargo Healthcare Conference

Thu, 27 Aug 2026 15:00:00 -0400

Portage, Michigan, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the 2026 Wells Fargo Healthcare Conference on Tuesday, September 8, 2026, at the Encore Boston Harbor.

Preston Wells, Vice President, Chief Financial Officer and Nick Mead, Vice President, Investor Relations will also participate in a fireside chat session at 2:15 p.m. (Eastern time). A simultaneous live audio webcast and replay of the session can be accessed at Stryker - Events & Presentations.

About Stryker

Stryker is a global leader in medical technologies and, together with our customers, we are driven

Stryker to participate in the 2026 Wells Fargo Healthcare Conference

Thu, 27 Aug 2026 15:00:00 -0400

Portage, Michigan, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the 2026 Wells Fargo Healthcare Conference on Tuesday, September 8, 2026, at the Encore Boston Harbor.

About Stryker

Stryker is a global leader in medical technologies and, together with our customers, we are driven

Form 4 STRYKER CORP For: Aug 21 Filed by: Crotty Dylan Bram

Wed, 26 Aug 2026 16:33:00 -0400

si-local-file:///var/storage/secattach/20260826/26982305.html

Form 4 STRYKER CORP For: Aug 21 Filed by: Crotty Dylan Bram

Wed, 26 Aug 2026 16:33:00 -0400

si-local-file:///var/storage/secattach/20260826/26982305.html

Stryker (SYK) 1900 contracts of September 340 calls trade

Tue, 25 Aug 2026 15:16:51 -0400

Stryker (NYSE: SYK) 30-day option implied volatility is at 29; compared to its 52-week of 18 to 40 with a focus on 1900 contracts of September 340 calls.

Form 4 STRYKER CORP For: Aug 18 Filed by: STRYKER RONDA E

Thu, 20 Aug 2026 17:12:00 -0400

si-local-file:///var/storage/secattach/20260820/26957158.html

Form 4 STRYKER CORP For: Aug 18 Filed by: STRYKER RONDA E

Thu, 20 Aug 2026 17:12:00 -0400

si-local-file:///var/storage/secattach/20260820/26957158.html

Form 4 STRYKER CORP For: Aug 18 Filed by: King Debra

Tue, 18 Aug 2026 16:35:00 -0400

si-local-file:///var/storage/secattach/20260818/26944862.html

Form 4 STRYKER CORP For: Aug 18 Filed by: King Debra

Tue, 18 Aug 2026 16:35:00 -0400

si-local-file:///var/storage/secattach/20260818/26944862.html

Form 144 STRYKER CORP Filed by: King Debra

Tue, 18 Aug 2026 12:44:00 -0400

si-local-file:///var/storage/secattach/20260818/26943067.html

Form 144 STRYKER CORP Filed by: King Debra

Tue, 18 Aug 2026 12:44:00 -0400

si-local-file:///var/storage/secattach/20260818/26943067.html

Form 144 STRYKER CORP Filed by: STRYKER RONDA E

Mon, 17 Aug 2026 10:13:00 -0400

si-local-file:///var/storage/secattach/20260817/26936214.html

Form 144 STRYKER CORP Filed by: STRYKER RONDA E

Mon, 17 Aug 2026 10:13:00 -0400

si-local-file:///var/storage/secattach/20260817/26936214.html

Wolfe Research downgrades Stryker, upgrades Abbott in med-tech shuffle

Thu, 13 Aug 2026 08:16:59 -0400

Investing.com -- Wolfe Research made two rating changes across large-cap medical devices, downgrading Stryker while upgrading Abbott Laboratories on Thursday.

Analyst Mike Polark cut Stryker to Peer Perform, citing a demanding second-half setup following the company's March cyber disruption.

He said the June quarter "wasn't a huge catch up thus year not yet de-risked," leaving "a higher-than-normal burden on 2H to deliver."

As a result, Wolfe sees the near-term skew to estimates "leans negative," with growth "more likely to slow to 8% vs speed up to 10% in 2027."

The firm flagged that Stryker's guidance

Wolfe Research downgrades Stryker, upgrades Abbott in med-tech shuffle

Thu, 13 Aug 2026 08:16:59 -0400

Investing.com -- Wolfe Research made two rating changes across large-cap medical devices, downgrading Stryker while upgrading Abbott Laboratories on Thursday.

Analyst Mike Polark cut Stryker to Peer Perform, citing a demanding second-half setup following the company's March cyber disruption.

He said the June quarter "wasn't a huge catch up thus year not yet de-risked," leaving "a higher-than-normal burden on 2H to deliver."

As a result, Wolfe sees the near-term skew to estimates "leans negative," with growth "more likely to slow to 8% vs speed up to 10% in 2027."

The firm flagged that Stryker's guidance

Wolfe Research Downgrades Stryker (SYK) to Peerperform

Thu, 13 Aug 2026 05:38:22 -0400

(Updated - August 13, 2026 5:38 AM EDT)

Wolfe Research analyst Mike Polark downgraded Stryker (NYSE: SYK) from Outperform to Peerperform.

The anlays tcomments "We’re looking at this stock fresh & wondering – where is the juice from here? In many ways this incremental reluctance stems from the unfortunate March cyber disruption. June quarter wasn’t a huge catch up thus year not yet derisked. SYK continues to view cyber disruption as a 2026 item which means there’s a higher-thannormal burden on 2H to deliver. Which leaves us feeling like (1) short-run skew leans negative to numbers & (2) even if delivered such

Wolfe Research Downgrades Stryker (SYK) to Peerperform

Thu, 13 Aug 2026 05:38:22 -0400

(Updated - August 13, 2026 5:38 AM EDT)

Wolfe Research analyst Mike Polark downgraded Stryker (NYSE: SYK) from Outperform to Peerperform.

StreetInsider.com News Articles

Form 4 STRYKER CORP For: Jun 26 Filed by: BRAINERD MARY K

Stryker completes first surgery using FDA-cleared Apple Vision Pro app

Stryker introduces first of its kind FDA-authorized surgical application for Apple Vision Pro with hip arthroscopy case at nationally recognized academic medical center

Stryker introduces first of its kind FDA-authorized surgical application for Apple Vision Pro with hip arthroscopy case at nationally recognized academic medical center

Stryker agrees to acquire ZuriMED to expand shoulder portfolio

Stryker agrees to acquire ZuriMED to expand shoulder portfolio

Stryker signs definitive agreement to acquire ZuriMED to enhance its shoulder offering

Stryker signs definitive agreement to acquire ZuriMED to enhance its shoulder offering

Stryker to participate in the 2026 Wells Fargo Healthcare Conference

Stryker to participate in the 2026 Wells Fargo Healthcare Conference

Form 4 STRYKER CORP For: Aug 21 Filed by: Crotty Dylan Bram

Form 4 STRYKER CORP For: Aug 21 Filed by: Crotty Dylan Bram

Stryker (SYK) 1900 contracts of September 340 calls trade

Form 4 STRYKER CORP For: Aug 18 Filed by: STRYKER RONDA E

Form 4 STRYKER CORP For: Aug 18 Filed by: STRYKER RONDA E

Form 4 STRYKER CORP For: Aug 18 Filed by: King Debra

Form 4 STRYKER CORP For: Aug 18 Filed by: King Debra

Form 144 STRYKER CORP Filed by: King Debra

Form 144 STRYKER CORP Filed by: King Debra

Form 144 STRYKER CORP Filed by: STRYKER RONDA E

Form 144 STRYKER CORP Filed by: STRYKER RONDA E

Wolfe Research downgrades Stryker, upgrades Abbott in med-tech shuffle

Wolfe Research downgrades Stryker, upgrades Abbott in med-tech shuffle

Wolfe Research Downgrades Stryker (SYK) to Peerperform

Wolfe Research Downgrades Stryker (SYK) to Peerperform